TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biopart AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
333
|
263
|
542 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-206
|
-319
|
57 |
| EBITDA |
-208
|
-321
|
57 |
| Total assets |
824
|
1,111
|
1,616 |
| Current assets |
824
|
1,111
|
1,616 |
| Current liabilities |
318
|
411
|
87 |
| Equity capital |
506
|
700
|
1,470 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
61.4%
|
63.0%
|
91.0% |
| Turnover per employee |
333
|
263
|
542 |
| Profit as a percentage of turnover |
-61.9%
|
-121.3%
|
10.5% |
| Return on assets (ROA) |
-25.0%
|
-28.7%
|
3.5% |
| Current ratio |
259.1%
|
270.3%
|
1857.5% |
| Return on equity (ROE) |
-40.7%
|
-45.6%
|
3.9% |
| Change turnover |
65
|
-317
|
-2,804 |
| Change turnover % |
24%
|
-55%
|
-84% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-50% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.